About
Atopic Dermatitis Treatment
Areas of Focus
Categories
Biologics & BiopharmaceuticalMicrobiomeSouthwestern U.S.
Team (10)
Antony A. Riley,Chief Financial Officer
,Chief Financial Officer
Forte Biosciences
executive
Barbara Finck, M.D.
Forte Biosciences
team_member
Barbara Finck, M.D.,Senior Medical Clinician
,Senior Medical Clinician
Forte Biosciences
team_member
Christopher Roenfeldt,Chief Operating Officer
,Chief Operating Officer
Forte Biosciences
executive
David Gryska
Forte Biosciences
team_member
Rich Vincent
Forte Biosciences
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
338
By Phase
PHASE1: 2PHASE2: 3
By Status
RECRUITING: 2NOT_YET_RECRUITING: 1TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07205159Lead Sponsor
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
PHASE1Not yet recruiting
32 participants
Started: Oct 15, 2025 · Completed: Dec 12, 2026
NCT06982963Lead Sponsor
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
PHASE2Recruiting
100 participants
Started: Aug 4, 2025 · Completed: Jun 30, 2026
NCT06905873Lead Sponsor
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
PHASE1Recruiting
16 participants
Started: Mar 25, 2025 · Completed: Jan 31, 2026
NCT04936113Lead Sponsor
Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
PHASE2Terminated
36 participants
Started: Jun 2, 2021 · Completed: Sep 30, 2021
NCT04504279Lead Sponsor
Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis
PHASE2Completed
154 participants
Started: Oct 13, 2020 · Completed: Aug 19, 2021
Locations (1)
Headquarters
Dallas, TX, United States
Map
Loading map...